Phigenix
Atlanta, US · Georgia corporation
Phigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.
BiotechHealthtechMedical Devices
Founders & leadership
CD
CARLTON D. DONALD, PH.DFounder
WH
WENNIFER H. DONALDExecutive
WH
Wennifer Holmes DonaldNamed on SEC filing
CD
Carlton D. Donald, Ph.DNamed on SEC filing
KE
Kenneth E. Robinson, M.D.Named on SEC filing
CD
Cynthia DayNamed on SEC filing
Board
RA
RICHARD A. ROY, M.D.Board director
CN
CYNTHIA N. DAYBoard director
KE
KENNETH E. ROBINSON, M.D.Board director
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 2 rounds · 2007–2014
▶$842.4KraisedAug 2015 · 14 investors · Other TechnologyRule 506(b)
▶$842.4KraisedAug 2015 · 14 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- WENNIFER H. DONALDExecutive Officer, Director
- CARLTON D. DONALD, PH.DExecutive Officer, Director
- RICHARD A. ROY, M.D.Director
- CYNTHIA N. DAYDirector
- KENNETH E. ROBINSON, M.D.Director
- Offering amount
- $10.5M
- Amount sold
- $842.4K
- Minimum investment
- $35K
- First sale
- Sep 2014
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
▶$3.7MraisedAug 2014 · 78 investors · Other TechnologyRule 506(b)
▶$3.7MraisedAug 2014 · 78 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Wennifer Holmes DonaldDirector
- Carlton D. Donald, Ph.DExecutive Officer, Director
- Kenneth E. Robinson, M.D.Director
- Cynthia DayDirector
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- Minimum investment
- $15K
- First sale
- Mar 2007
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Phigenix for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Phigenix do?
- Phigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.
- Who founded Phigenix?
- Phigenix was founded by CARLTON D. DONALD, PH.D.
- How much funding has Phigenix raised?
- Phigenix has disclosed $4.6M raised across 2 rounds.
- Where is Phigenix headquartered?
- Phigenix is headquartered in Atlanta, US.
